Discontinued — last reported Q1 '26
R&D at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s R&D?
- Elanco Animal Health Inc. (ELAN) reported R&D of $97M in Q1 2026.
- How has Elanco Animal Health Inc.'s R&D changed year-over-year?
- Elanco Animal Health Inc.'s R&D increased by 3.2% year-over-year, from $94M to $97M.
- What is the long-term trend for Elanco Animal Health Inc.'s R&D?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s R&D has grown at a -0.1% compound annual growth rate (CAGR), from $369M to $368M.
- What does R&D mean?
- The money spent on creating new products and improving existing ones.
- How do you interpret R&D?
- Increased spending signals a focus on future growth and innovation, while significant decreases might indicate a reduction in long-term competitive capability.
- How does R&D compare across companies?
- Standard in life sciences; compared as a percentage of revenue to assess the intensity of innovation efforts.